Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
Clinical trial NCT00053144 · COMPLETED
Trial details
- NCT number
- NCT00053144
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1999-11-01
- Primary completion
- 2003-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.